Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10726.25 -19.80 -0.18%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mylan Inc. (NASDAQ: MYL)

 
MYL Technical Analysis
1.5
As on 31st Oct 2017 MYL Share Price closed @ 35.71 and we RECOMMEND Sell for LONG-TERM with Stoploss of 37.48 & Buy for SHORT-TERM with Stoploss of 33.88 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MYL Share Price

Open 38.24 Change Price %
High 38.44 1 Day -2.53 -6.62
Low 34.72 1 Week 0.00 0.00
Close 35.71 1 Month -2.24 -5.90
Volume 17676410 1 Year -2.22 -5.85
52 Week High 45.87 | 52 Week Low 29.39
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
MYL
Daily Charts		 MYL
Intraday Charts		 Whats New @
Bazaartrend		 MYL
Free Analysis
 
MYL Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE39.16
RESISTANCE37.74
SUPPORT33.68
SUPPORT32.26
SUPPORT0.00
SUPPORT0.00
 
MYL Target for Month February
Share
4th UP TARGET52.38
3rd UP TARGET47.03
2nd UP TARGET43.73
1st UP TARGET40.42
1st DOWN TARGET31
2nd DOWN TARGET27.69
3rd DOWN TARGET24.39
4th DOWN TARGET19.04
 
MYL Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
MYL Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
MYL Other Details
Segment EQ
Market Capital 10603874304.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
 
MYL Address
MYL
 N/A
 
MYL Latest News
 
Your Comments and Response on Mylan Inc.
 
MYL Business Profile
Mylan Inc. (Mylan) is a fully integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan has two segments:Generics and Specialty. Its generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. The Company's pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). Mylan provides products to customers in approximately 140 countries and territories. In December 2013, In December 2013, the Company announced that it has completed the acquisition of the Agila injectables businesses from Strides Arcolab Ltd.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service